Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2006-10-03

Clinical Trial Update: Trial to Compare the Safety,Tolerability and Efficacy of Influenza Virus Vaccine, (CAIV-T) With Influenza Virus Vaccine, Trivalent, Inactivated (TIV) in Children [Phase 3]

View source ↗

Summary

This document reports a completed Phase 3 trial comparing the safety, tolerability, and efficacy of CAIV-T with the trivalent inactivated influenza vaccine in c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CAIV-T (live attenuated influenza vaccine)
  • Influenza vaccine, trivalent, inactivated (inactivated influenza vaccine, trivalent)

Snippet

Sponsor: MedImmune LLC | Conditions: Respiratory Tract Infections | Phase 3 | Status: COMPLETED